The World Health Organization has recognized the effectiveness of the Chinese Confidesia vaccine against the emerging Corona virus in emergency situations.

The World Health Organization has released a list of emergency use approvals for the Confidesia vaccine, manufactured by the Chinese company Cansino Biologics, which joins a growing group of vaccines approved by the World Health Organization for prevention (Covid-19). to the WHO official statement // Globalism.

The note clarifies that the Chinese vaccine is based on a genetically modified human adenovirus and requires a single dose.
Vaccine experts at the World Health Organization have also recommended the Confidsia vaccine for people aged 18 and over.

And the World Health Organization has indicated that the effectiveness of the Confidesia vaccine against the asymptomatic form of the Corona virus reaches 64%, and against the acute form of the disease it reaches 92%.
Thus, Confidesia is the 11th vaccine against the new Corona virus approved by the World Health Organization.